Risks ID'd for referral-warranted retinopathy of prematurity

Risks ID'd for referral-warranted retinopathy of prematurity

(HealthDay)—Predictors have been identified for referral-warranted (RW)-retinopathy of prematurity (ROP), according to research published online Dec. 18 in JAMA Ophthalmology.

Gui-Shuang Ying, Ph.D., from the University of Pennsylvania in Philadelphia, and colleagues examined predictive factors for the development of RW-ROP in a multicenter observational cohort.

The researchers found that 15.2 percent of the 979 infants without RW-ROP at first study-related who underwent at least two examinations developed RW-ROP. In multivariate analysis, the following were identified as significant predictors: male sex (odds ratio [OR], 1.80), nonblack race (OR, 2.76 for white; OR, 4.81 for other), low (OR, 5.16), younger gestational age (OR, 9.79), number of quadrants with preplus disease (OR, 7.12 for one to two quadrants; OR, 18.4 for three to four quadrants versus no preplus disease), stage 2 ROP (OR, 4.13), presence of retinal hemorrhage (OR, 4.36), the need for respiratory support (OR, 4.99 for controlled mechanical ventilator; OR, 11.0 for high-frequency oscillatory ventilation), and slow weight gain (OR, 2.44). The development of RW-ROP was predicted significantly better with these characteristics than with birth weight and (area under the receiver operating characteristic curve, 0.88 versus 0.78; P < 0.001).

"Using a model like the one presented here could help identify lower-risk infants who are less likely to develop RW-ROP and require less-frequent imaging or eye examinations," the authors write.

One author disclosed financial ties to Janssen Research and Development.

Explore further

Telemedicine catches blinding disease in premature babies

More information: Abstract
Full Text (subscription or payment may be required)
Journal information: JAMA Ophthalmology

Copyright © 2014 HealthDay. All rights reserved.

Citation: Risks ID'd for referral-warranted retinopathy of prematurity (2014, December 21) retrieved 24 October 2020 from https://medicalxpress.com/news/2014-12-idd-referral-warranted-retinopathy-prematurity.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments